Infectious diseases, along with cancers, are among the main causes of death among
humans worldwide. The production of therapeutic proteins for treating diseases at large …

The culture of Chinese Hamster Ovary (CHO) cells for modern industrial applications, such
as expression of recombinant proteins, requires media that support growth and production …

Cellular agriculture could meet growing demand for animal products, but yields are typically
low and regulatory bodies restrict genetic modification for cultured meat production. Here we …

Food systems of the future will need to face an increasingly clear reality–that a protein-rich
diet is essential for good health, but traditional meat products will not suffice to ensure safety …

This analysis examines the potential of “cultured meat” products made from edible animal
cell culture to measurably displace the global consumption of conventional meat …

A steady increase of product titers and the corresponding change in impurity composition
represent a challenge for development and optimization of antibody production processes …

There is growing interest in the possibility of developing truly continuous processes for the
large‐scale production of high value biological products. Continuous processing has the …

Apoptosis is a form of programmed and controlled cell death that accounts for the majority of
cellular death in bioprocesses. Cell death affects culture longevity and product quality; it is …

Cultured meat, as a cellular agriculture product, utilizes tissue engineering techniques and
consequently faces not only cell culture challenges but also scale-up limitations. To ensure …

Recombinant proteins, such as monoclonal antibodies, are produced in mammalian cell
lines to introduce proper protein folding and post‐translational modifications, which are …